---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-205527"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T00:42:58.487936+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Elevance Health names Mark Kaye new CFO to succeed retiring John Gallina; reaffirms 2023 guidance

## Summary
- Mark Kaye appointed EVP and CFO effective Nov 1, 2023; will serve as CFO Designate starting Sep 6.
- John Gallina retiring after ~30 years at company; will remain as Special Advisor to CEO post-transition.
- Kaye's compensation: base salary $900k, target bonus 120% of base, LTI target $5.5M; one-time awards: $8M RSUs, $3.7M equity mix, and $2.5M cash.
- Kaye previously CFO at Moody's (2018-2023), held senior finance roles at MassMutual and Voya.
- Company reaffirms FY 2023 adjusted net income guidance > $32.85 per share; net income > $29.09 per share.

## SEC filing metadata
- accession: 0001193125-23-205527
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312523205527/0001193125-23-205527-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312523205527/d492032d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-205527
- JSON: https://secwatch.observer/filing/0001193125-23-205527.json
- Plain text: https://secwatch.observer/filing/0001193125-23-205527.txt

## Key facts
- Executive change
  Mark Kaye was appointed as Executive Vice President and Chief Financial Officer at Elevance Health, Inc..
  - Action: appointed
  - Role: Executive Vice President and Chief Financial Officer
  source text: On August 8, 2023, Elevance Health, Inc. (the “Company”) announced that Mark Kaye has been named Executive Vice President and Chief Financial Officer (“CFO”) of the Company, effective November 1, 2023 (the “Transition Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000119312523205527/0001193125-23-205527-index.htm
- Executive change
  John Gallina retired as Chief Financial Officer at Elevance Health, Inc..
  - Action: retired
  - Role: Chief Financial Officer
  source text: Mr. Kaye succeeds John Gallina, who, after nearly thirty years of dedicated services to the Company, has decided to retire as CFO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000119312523205527/0001193125-23-205527-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.